Exchange: NASDAQ Sector: Healthcare Industry: Pharmaceutical Retailers
Current Signal: BUY (auto-tracking)
-3.05% $10.82
America/New_York / 25 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 436.76 mill |
EPS: | -0.700 |
P/E: | -15.46 |
Earnings Date: | May 08, 2024 |
SharesOutstanding: | 40.37 mill |
Avg Daily Volume: | 0.649 mill |
RATING 2024-04-25 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Strong Buy | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -15.46 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-2.12x |
Company: PE -15.46 | industry: PE 7.30 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 10.15 - 11.49 ( +/- 6.20%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-04 | Bhatia Naveen | Buy | 500 | Common Stock |
2024-03-21 | Yecies Eric Harold | Buy | 56 250 | Common Stock |
2024-03-21 | Stan Maria E. | Buy | 20 000 | Common Stock |
2024-03-21 | Galluppi Stefan | Buy | 30 000 | Common Stock |
2024-03-21 | Benathen Marc David | Buy | 75 000 | Common Stock |
INSIDER POWER |
---|
50.04 |
Last 93 transactions |
Buy: 4 012 942 | Sell: 1 185 724 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $10.82 (-3.05% ) |
Volume | 0.395 mill |
Avg. Vol. | 0.649 mill |
% of Avg. Vol | 60.78 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:33 | sell | $5.76 | N/A | Active |
---|
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.